ON-DEMAND WEBINARS

Watch a live build of compliant eCRFs and ePROs and see how lean teams can go from protocol to first patient faster without sacrificing regulatory readiness.

Consider new perspectives on 2023-issued guidance by the EMA and FDA, and how the amalgamation of these directives, combined with scientific insights, can empower sponsors and biotech firms.

Chief Scientific Officer Christine Guo, Ph.D., provides key insights into DHTs aimed at empowering study teams to strategically integrate these technologies into their clinical development initiatives.

Watch as industry experts explore the advancements in drug accountability facilitated through IRT, encompassing innovative methods for managing site variations and sustainable supply chains.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

John Oncea Editor